Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 110.2 SEK 0.64% Market Closed
Market Cap: 11.1B SEK
Have any thoughts about
Biogaia AB?
Write Note

EV/FCFF
Enterprise Value to FCFF

27.5
Current
27.7
Median
3.9
Industry
Lower than median
Higher than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
27.5
=
Enterprise Value
10B SEK
/
FCFF
365.2m SEK
All Countries
Close
Market Cap EV/FCFF
SE
Biogaia AB
STO:BIOG B
11.1B SEK 27.5
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 090.7
US
Abbvie Inc
NYSE:ABBV
314.9B USD 23.4
US
Amgen Inc
NASDAQ:AMGN
140.6B USD 30
US
Gilead Sciences Inc
NASDAQ:GILD
115.7B USD 11
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.9B USD -71.2
US
Epizyme Inc
F:EPE
94.1B EUR -469.1
AU
CSL Ltd
ASX:CSL
135.7B AUD 62.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.8B USD 21.3
US
Seagen Inc
F:SGT
39.3B EUR -56.6
NL
argenx SE
XBRU:ARGX
36B EUR -105.8

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More